Vivanza Biosciences Limited (VIVANZA.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-38453.8%

-₹552.29

vs ₹1.44 price

Levered DCF

-₹45.43

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	17.6×	-13×	50.79×	59.8×	107.81×	477.13×	-174.51×	-81.55×
P/B	1.59×	2.28×	6.13×	8.77×	10.27×	11.36×	11.63×	10.91×
P/S	0.06×	1.22×	1.02×	2.01×	3.45×	3.63×	3.73×	13.49×
EV / EBITDA	20.21×	-58.48×	29.85×	38.45×	53.52×	64.72×	1,599.68×	-2,032.83×
Gross margin	0.8%	8.1%	6.8%	5.6%	4.7%	3.9%	0.0%	8.5%
Operating margin	0.6%	-5.1%	3.9%	3.9%	0.6%	1.0%	-3.5%	-0.7%
Net margin	0.3%	-9.1%	2.0%	3.4%	3.2%	0.8%	-2.1%	-16.6%
Current ratio	1.13×	1.35×	1.29×	1.15×	1.3×	0.92×	0.99×	1.03×
Debt / equity	2.34×	2.18×	1.11×	1.95×	1.58×	0.11×	0.13×	0.45×
Interest coverage	2.55×	-1.07×	2.62×	1.63×	0.15×	0.21×	-0.75×	-0.05×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	9.0%	-17.0%	11.8%	14.6%	9.5%	2.4%	-6.7%	-13.4%
Return on invested capital	3.5%	-3.0%	8.8%	4.8%	0.7%	1.7%	-9.6%	-0.4%
Return on assets	1.8%	-4.1%	2.8%	2.7%	2.1%	0.9%	-1.7%	-4.0%
Free cash flow yield	-7.6%	-27.8%	7.1%	-0.6%	-1.5%	-9.1%	7.1%	1.2%
Earnings yield	5.7%	-7.5%	1.9%	1.7%	0.9%	0.2%	-0.6%	-1.2%
Enterprise value	₹170.7M	₹175.6M	₹334.4M	₹437.4M	₹413.3M	₹393.3M	₹390.5M	₹403.6M
Net debt / EBITDA	11.99×	-28.42×	4.47×	6.91×	7.06×	5.68×	129.67×	-225.75×
Cash conversion cycle (days)	36	458	64	192	232	146	135	606